![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: van Dongen G.A.M.S. Visser G.W.M. Vrouenraets M.B.
Publisher: Elsevier
ISSN: 0169-409X
Source: Advanced Drug Delivery Reviews, Vol.56, Iss.1, 2004-01, pp. : 31-52
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Monoclonal antibody conjugates in cancer therapy
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Recent Advances in Antibody-Drug Conjugates for Breast Cancer Treatment
Current Medicinal Chemistry, Vol. 24, Iss. 23, 2017-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Photosensitizer Nanoparticles for Photodynamic Therapy
Current Bioactive Compounds, Vol. 3, Iss. 4, 2007-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antibody-based antiangiogenic cancer therapy
By Sanz Laura Álvarez-Vallina Luis
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. :